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1. Abstract
providethe opportunity
Composite
magnetic
nanoparticles
for directtumortargeting,
thermal
therapy,andcontrolled
However,
drugrelease.
the magnetic
nanoparticles
mustbe biocompatible
in
orderto be usedin cancer
Bycoating
therapyapplications.
the magnetic
nanoparticles
with hydrogels,
we candecrease
theirtoxicitywhilemaintaining
theirproperty
of heating
in alternating
magnetic
fields.
Inthisstudy,it wasfoundthatwhenthe concentration
of nanoparticles
wasincreased,
cellviability
Inthe presented
decreased.
studies,
the heatgenerated
bythesenanoparticle
in analternating
systems
fieldwasnotenough
magnetic
to inducecelldeathbutit maybe possible.Forfuturestudies,
higher
concentrations
of particles
and/orlongerexposure
timesarerecommended
to inducecelldeath.
2. Introduction
2.l Hyperthermia
Canceristhe secondleadingcauseof deathin the UnitedStates;
thereforecancertherapy
research
isgaining
importance
amongtoday'sresearchers.
Eventhoughvastadvancements
in the
treatmentof cancerhavebeenmade,therearestillmanytypesof cancerthat haveverylowsurvival
ratesandpoortreatmentsuccess
rates.Thus,noveltherapies
basedon nanotechnologies
arebeing
pursued
duetheiruniqueproperties
andpotential
to improve
treatments.
Forexample,
composite
providethe opportunity
nanoparticles
magnetic
for directtumortargeting,
thermaltherapy,and
controlled
drugrelease
asshownin Figure
1.

i

I

o
A

-'I

lronoxide

a

o o
o

drug

+

a
H y d r o g ceol a t i n g

a--Anti-cancer

T

a

o

o

a

o
o
o
a

Figure1. lron oxidecoatedin a hydrogelprovidesthe opportunityfor controlleddrug release.

Hyperthermia,the heatingof cancertissueto between41 and 45'C, haspreviouslybeen proven
to inducecelldeathand when usedin conjunction
with other cancertreatments,suchas chemotherapy
and radiationtherapy,hasshown improvedefficacy[1]. However,there are manysetbacksto using
hyperthermia
asthe maintreatmentof cancer.The mostcommonformsof hyperthermia
todayare
whole bodyhyperthermia
and regionalhyperthermia.Wholebodyhyperthermia
utilizesheating
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hyperthermia
blanketsor water bathsin orderto elevatethe temperatureof the body. Regional
removesbloodsurrounding
the tumor site,heatsthe blood,and then pumpsit backinto the bodyand
discomfortaswell as burnsnearthe tumor site,and
throughthe tumor site. Many patientsexperience
it is difficultto havehomogeneous
distributionof heatacrossthe tumor site [2]. Dueto the lackof
to the cancertissue,healthytissuesurrounding
the cancertissueis often
abilityto localizehyperthermia
present
damaged.In the presence
of an alternatingmagneticfield,compositemagneticnanoparticles
within cancertissuedue to their superparamagnetic
the opportunityfor localized
hyperthermia
properties[3]. As the magneticfieldalternates,
heatcan be generatedthroughNeeland Brownian
In highenoughconcentrations
the heatgeneratedcouldinducecelldeath.
relaxation.
of nanoparticles,

2.2 Tumor targeting magneticnonoporticles
alsoprovidethe opportunityfor directtumor targeting.
Compositemagneticnanoparticles
whichconsistof a magneticcoreand a polymercoating
Thesecompositemagneticnanoparticles,
loadedwith anti-cancer
drug,can be injectedinto the tumor or directedto the tumor sitethroughthe
tissueis deformedand irregularwhichallows
useof an externalmagnet.Thevasculature
of cancerous
the nanoparticles
systemsto permeatethroughthe tissueand remaintheredue to the cancertissue's
and retentioneffect(EPR)[4,
inabilityto removewaste,otherwiseknownasthe enhancedpermeability
51. Uptakeof the nanoparticles
into the cellshasalsobeenobserved.Therefore,daughtercellsof the
particlecontainingparentcellsshouldcontainup to 50%of the originalparticleamount[3]. This
providesthe opportunityfor multipleheatingsessions
probabilityof inducingcell
and an increased
deathon descendants
of particlecontaining
cells.However,EPRtargetingmethodsdo not require
particleuptake.Localized
heatingof the tumor tissueis can be enoughto inducecelldeath.

2.3 Stealth and temperatureresponsivepolymers
is their biocompatibility,
The
Oneof the maindifficulties
of the compositemagneticnanoparticles
so the
healthytissuesurrounding
the tumor will be exposedto the compositemagneticnanoparticles
particlesshouldnot inducecelldeathunlessin the presence
of an alternatingmagneticfield. By coating
the iron oxide nanoparticles
with a biocompatiblepolymer,their cytotoxicityis decreased[6],
time increases
is a stealth
agglomeration
of particlesis preventedand circulation
[7]. PEG4OODMA
polymerusedto decrease
but it doesnot providethe
the toxicityof the iron oxidenanoparticle,
opportunityfor drug loadingand controlleddrugrelease.
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(PNIPAAm)
polymerwith a lowercritical
is a temperatureresponsive
Poly(N-isopropylacrylamide)
the polymeris hydratedand
solutiontemperature(LCST)
of about32 "Cin water. Belowthis LCST,
PNIPAAm
is hydrophobic
and collapses
on itself. Bycrosslinking
hydrophilic. Abovethe LCST,
PNIPAAMwith other polymers,the LCSTcan be increasedto abovebodytemperature.The behaviorof
polymersallowsfor anti-cancer
drugto be loadedinto the
PNIPAAm
and othertemperatureresponsive
polymerwhen it is belowthe LCST,
and then releasedduringthe suddencollapseabovethe LCST[5].
polymerswould allowfor anti-cancer
with temperatureresponsive
drug
Coatingmagneticnanoparticles
to be delivereddirectlyto the tumor site [8]. Heatingthe iron oxidecoreby an externalalternating
polymercoating.lf the polymercoatingwas
magneticfieldwould alsoheatthe temperatureresponsive
heatedto a temperatureaboveits LCST,
the polymerwouldcollapseand releasethe drug into the
with polymerdoesnot only
cancerous
tissue[9]. Therefore,coatingthe iron oxidenanoparticles
the toxicityof the particles,
but it alsoprovidesa methodfor directdrugdelivery.In this
decrease
(PEG40ODMA)was
usedto a
study,the stealthpolymerpoly (ethyleneglycol)400dimethylacrylate
includetestingthe toxicity
but plansfor futureexperiments
decreasein the toxicityof the nanoparticles,
polymersystems.
of nanoparticles
coatedwith temperatureresponsive
The overallobjectiveof this studywas to synthesizeand characterize
compositemagnetic
nanoparticles
for useas hyperthermia
and chemotherapeutic-based
treatmentsof cancer.More
specifically,
the goalswereto prepareiron oxidenanoparticles
coatedwith citricacidand PEG400DMA,
coated
comparethe viabilityof NIH3T3fibroblasts
and A549lungcancercellsexposedto PEG4OODMA
nanoparticle
iron oxidenanoparticles,
and to showincreased
toxicityin the presence
of an alternating
magneticfield.

3. Materialsand Methods
3.L Moterials
The iron (ll) chloridetetrahydrateand iron (lll)chloridehexahydrate
were purchased
from
(St.Louis,MO).Citricacidand ammoniumhydridewere obtainedfrom Sigma-Aldrich.
Sigma-Aldrich
(Bpy)and
were usedin polymerization
were also
The2,2-Dipyridyl
copper(l) bromide(CuBr)that
(BPTS),
purchased
was purchased
from Sigma-Aldrich.
The initiator,3-bromopropyltrimethoxysilane
(PEG400DMA)
glycol)400dimethylacrylate
and poly(Nfrom Gelest(Morrisville,
PA). Poly(elthylene
(PNIPAAm),
isopropylacrylamide)
whichwere monomersusedto coatthe iron oxidenanoparticles,
were purchased
from Polysciences,
lnc.(Warrington,
PA).
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i.2 lron oxide nanoparticlespreparation
Nanoparticle
systemswere createdusinga one-potco-precipitation
method. lron (lll)chloride
and iron (ll) chloridewere combinedin a 2:1 ratiorespectively
with NH4OHin a three neckflaskand
ventedwith nitrogengas. The temperatureof the systemwas set to 85'C,and the speedof the impeller
was set to 300 rpm. After the systemreachedthe specifiedtemperature,L.68gramsof 2M citricacid
was added.The reactionwascarriedout for one hour,and the nanoparticles
were separatedby
magneticdecanting,
washedwith ethanol,and vacuumdried.
In order to coat the iron oxide nanoparticles
with polymer,the nanoparticles
were first coated
(BPTS),
with an initiator,3-bromopropyl
via a ligandexchange
trimethoxysilane
with the citricacid.
BPTSputsbromineon the outsideof the nanoparticles
whichbecomesa radicalinitiatorwhen heated.
Thiscreates"seeds"for the polymercoating.BPTSand the iron oxide ratio are addedto a three-neck
flaskin a2.5:t ratio,respectively.
Thesystemwas purgedwith nitrogengasand then sealed.The
reactionwas run for 24 hoursat roomtemperaturewith the impellerrotatingat 300 rpm.

3.3 Polymerization techniques
ln order to coat the nanoparticlesin polymer,the stepsto coat the nanoparticles
with BPTS
initiatorwere first completed.The nanoparticles
were then addedto a three neckflaskwith Bpyand
CuBr,which were eachdiluted with ethanol. The systemwas set to run at 50'C,300 rpm and for 6
hours.When the systemreached60"C,5 gramsof PEG4OODMA
was added.After 6 hours,then
PEG400DMA
coatednanoparticles
were washedin ethanoland vacuumdried. Thissamepolymerization
techniquewas usedto synthesizethe pNIPAAmPNIPAAm-PEG400DMA
15 weight%coatediron oxide
nanoparticlesusedin the NIH3T3cytotoxicitystudyas well. The structuresof the polymersand initiator
are shownin Figure2.

PEG{n}DhlA
glycal}
BPT$initiator.
3-brornoprspyl
Poly{etthylene
n
lrimethorc;silane
dirnethy-lacryl
ate {n:400}
Figure2. Structuresof BPTSinitiator,PEG4OODMA
and PNIPAAm.

PNIPAAm:poly{Nisopropylacrylafiide)
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3.4 Characterization
FourierTransform
lnfrored(FTIR)Spectro.
Attenuatedtotal reflectanceFTIR(ATR-FTIR)was
used
to confirmthe existence
of specificfunctionalgroupson the surfaceof the iron oxidenanoparticles
usinga Varian7000eFTIRspectrophotometer.The spectrumwas obtainedfrom 800 to 4000cm-1
at a
resolutionof 8 cm-1for 32 scans.Driedcompositemagneticnanoparticles
sampleswere placedon the
diamondATRcrystalin orderto collectthe spectrum.
ThermogravimetricAnolysis(TGA).Weightpercent measurementswere obtained from a Q500
TA instrument.About 10mgof a samplewas usedat a heatingrateof 20 'C/min. Thesamplewas
heatedto l-20"Cand remainedtherefor 10 minutesin orderto evaporateany remainingwater. The
processwas completedunder nitrogenflow, and the TGAcurveswere normalizedto I2O"C.

3.5 Controlledheoting
lron oxidenanoparticles
coatedwith PEG400DMA
and NIAAm-PEG4OODMA
L5wt%were
suspended
in 4549 lungcancermediaand exposedto an alternatingmagneticfield. Eachof the
nanoparticle
systemswas addedto the mediaat concentrations
of 100Ug/mland 500;rg/ml,whichare
the sameconcentrations
the 4549 lungcancercellswere exposedto in the cytotoxicity
study. A one
millilitersampleof the nanoparticles
solutionwas placedinto a 2ml centrifugetube,whichwasthen
placedinsideTeflontube insidethe coil,and a fiberoptictemperatureprobe(LuxtronFOTLabKit)was
usedto recordthe temperatureof the nanoparticle
solutions.Thealternatingmagneticfieldwasturned
on 30 secondsafterthe starttime,and left on for 10 minutes.Thisprocedurewascompletedthree
timesfor eachconcentration
of the two nanoparticles
systems.

3.6 Cytotoxicity
NIH3T3murinefibroblasts
at passages
6-8 were culturedin Dulbecco's
ModifiedEagle's
(lnvitrogen)
Mediumsupplemented
with 70%v/v calfbovineserum,10 prg/mlFungizone
, and2 Ve/ml
(ATCC)
Penicillin-Streptomycin-Glutamine
in an incubatorat 37"Cand5%COz.Thefibroblasts
werethen
seededinto 12-wellplatesat 5000cells/cm2
and incubatedfor 24 hours. Cytotoxicitystudiesof 4549
lungcancercellswere alsocompleted.Forthesestudies,4549 lungcancercellsat passages
3 and 4
were culturedin F-12Kmediumsupplemented
with 70%fetalbovineserum,10 pg/ml Fungizone,
and 2
and seededinto 12-wellplatesat 6000cells
Ve/mlPenicillin-Streptomycin-Glutamine
f cmzandincubated
for 24 hours. After24 hours,the cellswere exposedto the variousconcentrations
of nanoparticles.
Nanoparticles
were addedto cellmediaat concentrations
of L00ir/mland 500p/ml.The nanoparticle
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solutionswere vortexedand sonicated
to dissolve
the nanoparticles
into the media.After removalof the
spentmedia,one milliliterof the nanoparticles
solutionswas addedto eachwell containing
the cells.
Thecontrol,whichwas exposedto no nanoparticles,
alsohad a changeof media.Thewell plateswere
then put backin the incubatorfor 24 and 48 hours.
Therewere two methodsof analyzingcytotoxicity.Thefirst techniquewas completedusingthe
cellometer(NexcelomBioscience,
Lawrence,MA).After 24 and48 hours,the cellswere removedfrom
the incubator,and the mediawas removedand placedinto respectivecentrifugetubes. The wellswere
then washedwith L25p1of trypsin,and then incubatedwith 250p1of trypsinto detachthe cellsfrom the
well plate. After incubating
for sevenminutes,the cellsand trypsinwere removedfrom the well plates
and placedinto the centrifugetubes. A 2ml DPBSwashwasthen completedto insureall the cellswere
beingcollected.
Thecellsolutionswere centrifuged
on a settingof threefor three minutes.The
supernatant
wasthen removedfrom the tubes,andthe cellswere re-suspended
in 0.5 ml of live/dead
assaysolution.Thecentrifugetubeswere then placedbackinto the incubatorfor 20 minutesto allow
the cellsto stain. After incubation,
three 20pl sampleswere takenfrom eachcentrifugetube and
analyzedusingthe cellometer.
Thecellometerprovidesthe cellviabilityof three 20gl samples,
whichare
then averagedto get the cellviabilityfor that trial.In additionto cellviability,the cellometeralsogives
the cellcount,cellconcentration,
and meansizeof the cells.
The secondanalyzingmethod usedin the cytotoxicitystudiesinvolveda fluorescentmicroscope
(NikonEclipse
LV100,Melville,NY)and N|S-Elements
BR3.0 imagingsoftware.After24 and 48 hours,
the cellswere removedfrom the incubator,and the mediawas removedand discarded.
The 2ml DPBS
washwasthen completedto removeall remainingmedia.After discarding
the DPBSwash,the live/dead
assaysolutionwasaddedat 0.5m1per well.Thecellswere then returnedto the incubatorfor 20
minutesbeforeimaging.Fiveimages(liveand dead)were takenof eachwell.The numberof liveand
deadcellsin eachimagewere then countedusingN|S-Elements
BR3.0 imagingsoftwareand averaged
to find the averagecellviabilityof eachwell.

3.7 Hyperthermia Demonstrotion
A hyperthermia
demonstration
wascompletedon 4549 lungcancercells.Thecellswere culturedin
F-12Kmediaand seededinto 35mm dishesat 6000cells/cm2.After seedingfor 24 hours,the cellswere
exposedto the nanoparticles
solutions.Forthis study,cellswere exposedto citricacidcoatediron
(100pg/ml
oxidenanoparticles,
and PEG400DMA
coatediron oxidenanoparticles.
Two concentrations
and SOOprg/ml)
of eachsystemwere studied. The first controlwas cellsnot exposedto particles,but
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field,andthe secondcontrolwascellswhichwereneitherexposed
magnetic
exposed
to the alternating
the
to the nanoparticles
solutions,
magnetic
field. Afterexposure
to nanoparticles
or the alternating
to thealternating
for threehours.Thecellswerethenexposed
cellswereplacedin the incubator
to the
on the stage,
centered
on the coil,andexposed
field.The35mmdishes
wereplaced
magnetic
magnetic
field,the dish
of the alternating
magnetic
fieldfor 10minutes.Aftertermination
alternating
for two hours.Cellswerethenstained
wasremovedfromthe stageandplacedbackintothe incubator
greenandthedeadcellsare
sothe livecellsarestained
AM andethidiumhomodimer-l
withCalcien
1V100
fluorescent
microscope
andNISred. Eachdishwasthenimagedusingthe NikonEclipse
stained
BR3.0imaging
Elements
software.

4. Results
andDiscussion
4.7 Choracterization
andNIPAAm-PEG400DMA
coatedin PEG400DMA
TheFTIR
results
for ironoxidenanoparticles
the presence
In Figure3, the linedrawnat 17L5cm-1indicates
areshownin Figures
3 and4 respectively.
to the C-O-C
bonds.In Figure
cm-1locates
the valleycorresponding
of a C=Oandthe linedrawnat 1.105
1
the C=Ostretch
to the peakswhichrepresent
4, the linesdrawnat 1655cm-1andL620cm correspond
of
the presence
to N-Hbending.Therefore,
the valleywhichcorresponds
and1540cm-1locates
dueto the presence
of thesepeaksand
15wt%is confirmed
PEG400DMA
andNIPAAm-PEG400DMA
valleys.
-BPTS
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Figure3. FTIRspectraof citricacidcoatediron oxide,BPTSinitiator,and functionalization
PEG4OODMA.
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I5wt%
Thermogravimetric
canalsobe usedto confirmthe presence
of a polymercoatingon
analysis
the ironoxidenanoparticles
andquantifythe weightpercentof polymer,but it alsoconfirmsthe theory
with polymerincreases
ThecitricacidcoatinB
that coatingthe ironoxidenanoparticles
theirstability.
beginsto degradeat a lowertemperature
thanthe PEG400DMA
coatingasdisplayed
in Figure5. The
whichfurtherconfirmsan
rateof degradation
isalsomuchhigherfor citricacidthanPEG400DMA,
in stabilityby coatingthe nanoparticles
with polymer.
Thefinalweightof the nanoparticles
increase
coatedin
coatedwith citricacidis alsogreaterthanthe finalweightof the ironoxidenanoparticles
PEG400DMA,
indicating
a greatercoatingof polymerthancitricacid.Inthe PEG400DMA
coatediron
is polymer,andthe other88%isthe iron
oxidenanoparticles,
approximately
L2%of the nanoparticle
oxidecore.

L0
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Figure5. TGAof citric acidcoatediron oxide nanoparticles
and PEG400DMA,
BPTSinitiator,coatediron
oxidenanoparticles.
TheAMF heatingcapabilities
of the compositemagneticnanoparticles
were determinedusing
alternatingmagneticfieldheating.The particles
were suspended
in F-12K4549 lungcancercell
medium,at variousconcentrations.
As the concentration
of nanoparticles
in the cellmediumincreased,
the amountof heatgeneratedduringexposureto an alternatingmagneticfield alsoincreased.lt was
alsoobservedthat the nanoparticles
coatedin NIPAAm-PEG4OODMA
Liwt% were heatedto greater
temperaturesthan thosecoatedin PEG400DMA
at both concentrations.Sincethe nanoparticles
do
generateheatin the presence
of an alternatingmagneticfield,as shownin Figure6, this presentsthe
questionof whether the heat generatedis enoughto be usedas hyperthermiato inducecell death.

l_1
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o
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to

5500

uglml
PEG4OODMA
' 100 uglml NIPAAmPEG4hDMA
m500
uglml NtPAAmPEG4hDMA

Time (s)

in F-12Kmediumin an alternating
Figure6. Heatingprofilesof compositemagneticnanoparticles
magneticfield strengthof 59.5kA/m.

4.2 Cytotoxicity of composite magnetic nanoparticles
studieswere
NIH3T3fibroblasts
modela commoncelltypefound in the body. Cytotoxicity
interactwith and effect
completedon this celllineto modelhow compositemagneticnanoparticles
Fe3Oa
coated
systems:Fe3Oa,
non-cancerous
cells. NIH3T3were exposedto four different nanoparticles
15wt%coatediron oxide.
coatediron oxide,and NIPAAm-PEG400DMA
with citricacid,PEG400DMA
(100Ug/ml,500prg/mland Lmg/ml)of eachnanoparticles
systemwere used. Cell
Threeconcentrations
imaging.Fiveimageswere takenper well. The liveand
were calculated
viabilities
usingmicroscope
with the other imagesof that well. Then,the three
deadcellsin eachimagewere countedand averaged
wells of the samenanoparticlesystemand concentrationwere averagedto get an overallcell viability.
exposedto the 100pg/ml
of the NIH3T3fibroblasts
Figure7 showsthat the cellviabilities
nanoparticles
solutionswere not significantlydifferentfrom the control (not exposedto nanoparticles)
solutionsprovedto be moretoxicto the cellsthan the
cellviability.The 500pg/mlnanoparticles
coatediron oxidewere the only
1-00pg/mlconcentration.lron oxidewithout coatingand PEG400DMA
systemswith not significantlydifferentcellviabilitiesfrom the controlfor either48 or
two nanoparticles
24 hours. The Lmg/ml concentrationappearsto be very toxic due to all nanoparticlesystems,exceptfor

L2
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PEG4OODMA
coated,to havea significantdifferencein cellviabilityfrom the control. Thistrend of
increasing
nanoparticles
decreasing
cellviabilityis to be expected.
concentration,
Within eachconcentrationof nanoparticles,
it was expectedthat the polymercoated
nanoparticles
would increasecellviabilitywhen comparedto the non-coated
iron oxideand citricacid
coatediron oxide. Althoughin manycasesthe viabilityof the cellsexposedto polymercoated
nanoparticles
was greaterthan the others,it was not significant,as shown in Table1. The p-values
comparingthe non-coated
to the polymercoated
and citricacidcoatediron oxidecorenanoparticles
nanoparticles
were greaterthan 0.05,not indicatinga significantdifference.However,there was a
significantdifferencebetweenincreasingconcentrations
of the samenanoparticles
systems.Therefore,
we cansaywith confidence
that increasing
the nanoparticles
concentration
doesdecrease
cellviability.
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Figure7. NIH3T3fibroblastcellviabilityafter exposureto Fe3O4,Fe3O4+CA
and PEG400DMA
nanoparticles.
Darkbarsrepresent24 hoursand lightbarsrepresent48 hours.Theerror is reportedas
standarderror.
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itatisticalAnalysis
of NIH3T3Viabilities

100uglml i00 uglml I mg/ml
:e3O4(24 hours)
:e3O4(48 hours)

3>0.05

:e3O4+ CitricAcid (24 hours)
:e3O4+ CitricAcid (48 hours)

r>0.05

)EG400DMA
(24 hours)
,EG400DMA
(48 hours)

0>0.o5

r>0.05
'>0.05
r>0.05
l>o.05

c>0.05

)>0.05

Table1. Statistical
analysis
of NIH3T3fibroblastviabilities.
Thistablecomparesthe viabilities
of the
controlcellsto the cellswhichhavebeenexposedto nanoparticle
systems.
A p-valuegreaterthan 0.5
(shadedin green)indicatesno significant
differencebetweenthe controlviabilityand the nanoparticle
systemviability.A p-valuelessthan 0.5 (shadedin red)indicatesa significant
differencein cellviability
betweenthe controland the nanoparticlesystem,therefore,they could be consideredtoxic.

Cytotoxicity
studieswith 4549 lungcancercellswere alsocompletedto determinehow the
compositemagneticnanoparticles
interactwith cancercells.The cellswere culturedas statedabove,
and exposedto two nanoparticle
systemsand two concentrations
of eachsystem.Cellviabilities
were
calculated
usingthe cellometermethodoutlinedin the materialsand methodssection.
As with the NIH3T3fibroblasts,
the 100pg/mlnanoparticle
solutionsdo not significantly
decrease
cellviabilityas shownin Figure8. Onlythe 100p/mlPEG4OODMA
becametoxicafter48 hours. Not
experiencing
a significant
decrease
in the viabilityof cellsexposedto the 100pg/mlconcentrations
of
the nanoparticle
systems,
couldindicatebiocompatibility
at this concentration.However,when the
concentration
is increased
to 500pg/mlall the nanoparticle
systemscauseda decreasein cellviability,
exceptwhen exposedto PEG400DMA
for only 24 hours.
A549lungcancercellsdid not experience
a significant
drop in viabilitywhen the concentration
of
the samenanoparticle
systemwas increased.Forexample,Table2 doesnot showa statistical
differencebetweenthe viabilitiesof cellsexposedto 100pg/mlFe3Oo+CA
and doesshow a statistical
significance
to thoseexposedto 500pg/mlFe3Oo+CA
after 24 hourswhen comparedto the control.

1.4
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Figure8. A549lungcancercellviabilities
24 and48 hoursafterexposure
to ironoxidecoatedin citric
Erroris reportedasstandard
acidandPEG400DMA
coatedirofroxidenanoparticles.
error.
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tatisticalAnalysis
of A549lungcancerviabilities

100uglml
3O4+ CitricAcid(24 hours)
3O4+ CitricAcid(48 hours)
G400DMA(24 hours)

A (48hours)
Table2. Statstical
analysis
of A549lungcancercells.A p-valuegreaterthan 0.5 (shadedin green)
indicatesno statistical
differencebetweenthe controlviabilityand the nanoparticle
system.A p-value

T6
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lessthan 0.5 (shadedin red)indicatesa significant
differencebetweenthe controlviabilityand the
nanoparticlesystem,therefore,they could be consideredtoxic.

4.3 Hypertherm i a Dem onstrati on
4549 lungcancercellswhichhad beenexposedto compositemagneticnanoparticles
were also
exposedto an alternatingmagneticfield,in hopesof provingthat the heatgeneratedby the
nanoparticles
is enoughto inducecelldeath. Figure5 showedthat in the presence
of an alternating
magneticfield,the magneticnanoparticles
do generateheat. However,when the cellsand
nanoparticles
were exposedto the samealternatingmagneticfield,the heatgeneratedwas not enough
toinducecelldeath
T .h e i m a g e s i n F i g u r e l 0 w e r e t a k e n a t t h e c e n t e r o f t h e 3 5 m m d
T ihsehc. e l l s i n
theseimagesare alivewith minimaldeadcells.Hadthe heatgeneratedby the particlesbeenenoughto
inducecelldeath,it would havebeenexpectedto seea majorityof deadcellat the centerof the dish. lt
is possible
to increase
the heatgeneratedby increasing
the nanoparticle
concentrations,
however,this
couldalsodecrease
cellviabilityin cellsnot exposedto an alternatingmagneticfield. Future
experiments
will be completedto determinethe optimumconcentration
of nanoparticles
that will both
generateenoughheatto inducecelldeathand allowfor highcellviabilitywhen not exposedto an
alternatingmagneticfield.

Control-NoAM F/No particles

Control-AMF/No particles
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100ug/mlFe3O4+CA

100ug/mlPEG400DMA

500ug/mlFe3O4+CA

500ug/mlPEG400DMA

Figure10. Live/deadimagesof A549cellsexposedto nanoparticlesystemsand then exposedto an
alternatingmagneticfieldfor l-0 minutes.

5. Conclusions
It wasfoundthat increasing
concentration
to whichcellsare exposed,
the nanoparticle
cellviability.Thistrendwas observedwhen usingboth NIH3T3fibroblasts
and 4549 lung
decreases
cancercells.The 100pg/mlconcentration
of the nanoparticle
solutionsdid not producesignificantly
differentcell viabilitiesfrom the control,and thereforecould be consideredbiocompatible.However,as
the concentration
was increased,
the nanoparticles
becametoxicto the cells,asthe cellviabilities
becamesignificantlylessthan the control. In the future, we hope to provethat by coatingiron oxide
nanoparticles
with polymerit is possible
Whilesomeof the results
to makethem more biocompatible.
supportthistrend,the resultsare not significant.
When magneticnanoparticle
suspended
in 4549 cellmediawere exposedto an alternating
generatedheat.However,this heatwas not enoughto inducecell
magneticfield,the nanoparticles
18
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deathwhen both A549lungcancercellsand magneticnanoparticles
were exposedto an alternating
magneticfield. Thiscouldbe due to the concentration
of nanoparticles
not beinghighenough,but the
concentrations
must remainlow enoughso that cellviabilitywhen not exposedto the alternating
magneticfield remainshigh. Therefore,
the nextstepof this research
will be to developnanoparticles
that generateenoughheatin an alternatingmagneticfieldto inducecelldeath,but do not inducecell
death otherwise.
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